other material
confidence high
sentiment neutral
materiality 0.55
Calidi Biotherapeutics raises $2M in registered direct offering and private placement of warrants
Calidi Biotherapeutics, Inc.
- Sold 2,050,000 shares at $1.00 per share in a registered direct offering.
- Concurrent private placement: Series E and F warrants to purchase up to 2,050,000 shares each at $1.13, exercisable after 6 months.
- Gross proceeds ~$2 million; net proceeds for working capital and clinical trials.
- Placement agent Ladenburg Thalmann receives 8% cash fee and warrants for 102,500 shares at $1.25.
- Lock-up agreements: Company 30 days, directors/officers 90 days from closing.